Table 1.
AD patients | Control (n=160) | t-value/χ2 statistic | P-value | |
---|---|---|---|---|
Age, years, mean (SD) | 68.9 (11.8) | 69.6 (12.5) | 0.145 | 0.892a |
Male, n (%) | 63 (42.9) | 66 (41.3) | 0.081 | 0.776b |
Smoker/nonsmoker | 72/75 | 78/82 | 0.158 | 0.691b |
Drinker/nondrinker | 73/74 | 79/81 | 0.003 | 0.960b |
Education level (>9 years), n (%) | 32 (21.8) | 34 (21.3) | 0.012 | 0.912b |
Spouse, n (%) | 132 (89.8) | 136 (85.0) | 1.589 | 0.207b |
Career (working overtime), n (%) | 93 (63.3) | 98 (61.3) | 0.132 | 0.716b |
Anxiety (cutoff score 8 in Hospital Anxiety and Depression Scale), n (%) | 44 (29.9) | 5 (3.1) | 41.044 | 0.000b |
Current medication, n (%) | ||||
Antidepressant medication | 51 (34.7) | 0 | 152.031 | 0.000b |
Selective serotonin-reuptake inhibitors | 63 (42.9) | 0 | 86.276 | 0.322b |
Serotonin–noradrenaline-reuptake inhibitors | 21 (14.3) | 0 | 24.535 | 0.000b |
Psychiatric test scores, mean (SD) | ||||
Montgomery–Åsberg Depression Rating Scale | 23.9 (7.8) | 14.2 (2.4) | 2.141 | 0.004a |
Anxiety score (Hospital Anxiety and Depression Scale) | 12.6 (4.5) | 4.3 (1.1) | 2.649 | 0.002a |
Global Assessment of Functioning score | 59.4 (6.8) | 78.1 (8.3) | 3.517 | 0.001a |
Toronto Alexithymia Scale – 20 | 54.6 (13.8) | 23.2 (6.3) | 4.388 | 0.001a |
RAND-36 score | 52.3 (16.1) | 83.6 (10.9) | 3.046 | 0.002a |
MMSE scores | 19.8±4.9 | 31.8±4.3 | 3.061 | 0.002a |
CDR scale | ||||
CDR 0, n | 0 | 160 | 307.021 | 0.000b |
CDR 0.5, n | 84 | 0 | 125.868 | 0.000b |
CDR 1, n | 36 | 0 | 44.388 | 0.000b |
CDR 2+, n | 27 | 0 | 32.221 | 0.000b |
Notes:
Student’s t-test;
standard χ2 statistic.
Abbreviations: AD, Alzheimer’s disease; SD, standard deviation; MMSE, Mini-Mental State Examination; CDR, Clinical Dementia Rating.